Mirae Asset Global Etfs Holdings Ltd. Phathom Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 22,149 shares of PHAT stock, worth $112,073. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,149
Previous 18,741
18.18%
Holding current value
$112,073
Previous $338,000
47.04%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PHAT
# of Institutions
158Shares Held
68.6MCall Options Held
52.3KPut Options Held
635K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$51.2 Million4.92% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$37.8 Million13.31% of portfolio
-
Jennison Associates LLC7.06MShares$35.7 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA3.67MShares$18.6 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$17.7 Million28.4% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $198M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...